Tatva Chintan Pharma Chem Limited IPO
Tatva Chintan Pharma Chem Limited IPO is listed on BSE and NSE, priced at ₹1073–₹1083 per share. The stock debuted at ₹2111.85, delivering a listing gain of 95.0%. The IPO had a lot size of ₹13 shares and a minimum investment of ₹14,079.
Tatva Chintan Pharma Chem Limited IPO
- IPO Dates
- Jul 16, 2021 – Jul 20, 2021
- Price band
- ₹1073-1083 per equity share
- Minimum Investment
- ₹14,079
- Issue size
- 500 Cr(225 Cr Fresh Issue + 275 Cr Offer for Sale)
- Lot size
- 13
- Allotment Date
- Jul 26, 2021
- Listing
- Jul 29, 2021
- Listing At
- BSE, NSE
IPO timeline
-
Jul 16, 2021
Open Date
Completed
-
Jul 20, 2021
Close Date
Completed
-
Jul 26, 2021
Allotment Date
Completed
-
Jul 29, 2021
Listing Date
Completed
Price Summary
- Last closing
- 1,260.00 (16.34%)
- 52 week high
- 1,610.00
- 52 week low
- 749.65
- Last update
Tatva Chintan Pharma Chem Limited IPO Essentials
Tatva Chintan Pharma Chem Limited IPO Details
Tatva Chintan Pharma Chem Limited IPO is priced at ₹1073-1083 per share with a total issue size of 500 Cr(225 Cr Fresh Issue + 275 Cr Offer for Sale). The IPO has a lot size of 13 shares and is listed on BSE and NSE.
- Issue price
- ₹1073-1083 per equity share
- Lot size
- 13 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 500 Cr(225 Cr Fresh Issue + 275 Cr Offer for Sale)
- Listing at
- BSE, NSE
- List price
- 2111.85(NSE)
- Listing date
- Registrar
- Link Intime India Private Ltd
- Lead manager
-
ICICI Securities Limited, JM Financial Consultants Private Limited
Tatva Chintan Pharma Chem Limited IPO Analytics
Tatva Chintan Pharma Chem Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Tatva Chintan Pharma Chem Limited IPO Subscription Status
Tatva Chintan Pharma Chem Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB |
NII
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 9,31,966 |
6,98,975
|
16,30,941 | 32,61,882 |
|
Day 1
16-07-20 05:00 PM
|
0.51 x |
1.13x
|
8.25 x | 4.51 x |
|
Day 2
19-07-20 05:00 PM
|
1.97 x |
12.21x
|
23.74 x | 15.05 x |
|
Day 3
20-07-20 05:00 PM
|
186.96 x |
516.99x
|
35.67 x | 182.04 x |
|
Total No. of Applications
|
category wise applications | ||
|---|---|---|---|
| 3244130 (Approx) | 26.10 | ||
Tatva Chintan Pharma Chem Limited Valuations
Earnings
- EPS (Post IPO)
- ₹23.64/-
- P/E Ratio
- 45.80
Returns
- RoNW
- 31.49%
Tatva Chintan Pharma Chem Limited Financials( In Crs.)
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | 31-Mar-18 | |
|---|---|---|---|---|
| Assets | 314.80 | 248.94 | 187.51 | 143.72 |
| Revenue | 306.29 | 264.62 | 206.8 | 137.29 |
| Profit After Tax | 52.26 | 37.79 | 20.54 | 12.29 |
Tatva Chintan Pharma Chem Limited Company & Offer Insights
About Tatva Chintan Pharma Chem Limited
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
Tatva Chintan Pharma Chem Limited Promoter(s)
Ajaykumar Mansukhalal Patel, Chintan Nitinkumar Shah, Shekhar Rasiklal Somani are the company's promoters of Tatva Chintan Pharma Chem Limited.
Tatva Chintan Pharma Chem Limited IPO Issue Objectives
- •
- Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
- •
- Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
- •
- To meet general corporate purposes.
Tatva Chintan Pharma Chem Limited IPO - Anchor Investors
Tatva Chintan Pharma Chem mobilises Rs 150 crore from anchor investors ahead of IPO
Marquee global investors who participated in the anchor book were Goldman Sachs, HSBC Global, Abu Dhabi Investment Authority, Aberdeen Standard Asia, and Nomura.
Axis MF, Aditya Birla Sun Life, Nippon Life, SBI Life Insurance, SBI MF, ICICI Prudential, and HDFC Trustee are among domestic investors invested in the specialty company through anchor book.
Tatva Chintan Pharma Chem Limited IPO - Peers Comparison
| P/B Ratio | P/E Ratio | RoNW | Revenue(in Cr.) | |
|---|---|---|---|---|
| Tatva Chintan Pharma Chem Limited | 13.11 | 45.80 | 31.49% | 306.29 Cr |
| Aarti Industries Limited | 7.79 | 28.46 | 15.05% | 4,506.80 Cr |
| Navin Fluorine International Limited | 11.62 | 73.63 | 18.13% | 1,258.43 Cr |
| Alkyl Amines | 9.48 | 26.40 | 37.27% | 1,249.38 Cr |
| Vinati Organics | 12.88 | 73.58 | 17.45% | 980.10 Cr |
| Fine Organics Industries | 12.64 | 78.47 | 15.56% | 294.41 Cr |
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Tatva Chintan Pharma Chem Limited IPO is a book-built IPO worth ₹500 Cr(225 Cr Fresh Issue + 275 Cr Offer for Sale). The price band is ₹1073–₹1083 per share. The IPO opens on Jul 16, 2021 and closes on Jul 20, 2021. It will be listed on BSE and NSE. Link Intime India Private Ltd is the registrar.
The price band of Tatva Chintan Pharma Chem Limited IPO is ₹1073 to ₹1083 per share.
The lot size of Tatva Chintan Pharma Chem Limited IPO is 13 shares.
The minimum investment for Tatva Chintan Pharma Chem Limited IPO is approximately ₹14,079 based on the upper price band .
Tatva Chintan Pharma Chem Limited IPO opens on Jul 16, 2021 and closes on Jul 20, 2021.
The allotment date of Tatva Chintan Pharma Chem Limited IPO is Jul 26, 2021.
Tatva Chintan Pharma Chem Limited IPO is expected to be listed on Jul 29, 2021, on BSE and NSE .
Tatva Chintan Pharma Chem Limited IPO listed on Jul 29, 2021. It was issued at ₹2111.85(NSE) and is currently around ₹1260.00 as on 14-May-2026 3:30 PM, which is approximately 16.3% versus issue price. The 52-week high is ₹1,610.00.
Based on listing and post-listing performance, Tatva Chintan Pharma Chem Limited IPO delivered around 16.3% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Tatva Chintan Pharma Chem Limited IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
Tatva Chintan Pharma Chem Limited IPO valuation snapshot: P/E 45.80, EPS ₹23.64/-, P/B N/A, RoNW 31.49%, and market cap N/A.
To apply for Tatva Chintan Pharma Chem Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Tatva Chintan Pharma Chem Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Tatva Chintan Pharma Chem Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Tatva Chintan Pharma Chem Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Tatva Chintan Pharma Chem Limited IPO allotment status on IPO Ji for quick and easy access.